Skip to content

Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy

Esketamine for the Prevention of Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy: a Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06579937
Enrollment
172
Registered
2024-08-30
Start date
2024-09-02
Completion date
2025-10-30
Last updated
2024-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior Problem

Keywords

esketamine, postoperative negative behavioral change, pediatrics, emergence delirium, tonsillectomy, adenoidectomy

Brief summary

The goal of this clinical trial is to learn the effect of intravenous esketamine in postoperative negative behavior changes in children compared to placebo (a look-alike substance that contains no drug). It will also learn about the effect of esketamine in emergence delirium. The main questions are: Dose esketamine lower the incidence of postoperative negative behavior changes compared to placebo? Dose esketamine lower the incidence of emergence delirium compared to placebo? Researchers will compare esketamine to placebo to see if esketamine works to treat postoperative negative behavior change and emergence delirium. Participants will: Receive intravenous esketamine or placebo (a look-alike substance that contains no drug) during anesthesia induction; Fill in the Post hospitalization behavior questionnaire for ambulatory surgery postoperative 1, 7, and 30

Detailed description

Approximately half of children who undergo general anesthesia experience emergence delirium (ED) and postoperative negative behavioral changes (PNBC). There was a positive correlation between delirium during recovery and the change in negative behaviour after the operation. Esketamine has sedative, analgesic and anti-traumatic stress effects. Based on literature analysis and preliminary trials, this study suggests that intraoperative use of low-dose esketamine may reduce the incidence of emergence delirium and postoperative negative behavior changes in children. This prospective randomized controlled trial was conducted to compare the effect of intravenous esketamine in the incidence of emergence delirium and postoperative negative behavior changes in children compared to placebo (a look-alike substance that contains no drug) to provide a reference for optimizing clinical anesthesia medication regimens.

Interventions

During anesthesia induction, a 0.2 mg/kg esketamine bolus was administered intravenously.

DRUGnormal saline

During anesthesia induction, a bolus of equal 0.9% saline was administered intravenously.

Sponsors

Fujian Provincial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
3 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

* American society of Aneshesiologists physical status I or II; * Aged 3-7 years; * Scheduled for elective tonsillectomy and (or) adenoidectomy.

Exclusion criteria

* Parents refusing to allow their children to participate; * Intake of sedative or analgesic medication within 48 hours before surgery; * Developmental delay; * Psychosis; * Body mass index \> 30 kg/m2; * Allergy to study drugs; * Major life changes 1 month before the operation, such as the divorce of parents, death of parents, moving to a new home, changing to a new kindergarten, etc.; * Any other conditions that precluded study inclusion.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of postoperative negative behavior changesPostoperative day 7Postoperative negative behavior changes were assessed with Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS).

Secondary

MeasureTime frameDescription
Incidence of emergence deliriumWithin 30 minutes after extubationEmergence delirium was assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale (defined as a PAED score of ≥10).
Postoperative pain intensityWithin 30 minutes after extubationPostoperative pain intensity will be measured using the face, legs, activity, cry, and consolability scale.
Preoperative anxietyBefore the intervention in holding areaPreoperative anxiety will be assessed using the modified Yale preoperative anxiety scale. Scores range from 23 to 100 with higher scores indicating greater anxiety.
Incidence of postoperative negative behavior changesPostoperative day 1Postoperative negative behavior changes were assessed with Post Hospitalization Behavior Questionnaire for Ambulatory Surgery (PHBQ-AS).
Parental satisfactionPostoperative day 1Parental satisfaction is self-reported using a five-point Likert scale (5=very satisfied, 4=satisfied, 3=neither satisfied nor dissatisfied, 2=dissatisfied, and 1=very dissatisfied).
Length of postanesthesia care unit stayUp to 60 minutes postoperativelyLength of postanesthesia care unit (PACU) stay is defined as the time between arrival in the PACU and readiness for discharge from the PACU (defined as a modified Aldrete score of ≥9).
Incidence of adverse eventsUp to 24 hours postoperativelyAdverse events such as bradycardia, tachycardia, hypertension, hypotension, and hypoxia will be recorded during the trial.
Emergence timeAbout up to 30 minutes postoperativelyEmergence time is defined as the interval from discontinuation of inhalation anesthetic to eye-opening on verbal command.

Countries

China

Contacts

Primary ContactYusheng Yao, MD&PhD
fjslyys@fjmu.edu.cn13559939629
Backup ContactSisi Chen, MD
chensisi49@163.com15080109541

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026